A carregar...
HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer
BACKGROUND: Aberrant activation of the signal transducer and activator of transcription 3 (STAT3) is frequently seen in patients with gastric cancer (GC), and is generally associated with worse prognosis. HJC0152, a novel STAT3 inhibitor, has shown significant anti-tumor effects in several cancers,...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6296682/ https://ncbi.nlm.nih.gov/pubmed/30588091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S188364 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|